Calistoga Pharmaceuticals Inc.
|
|
|
|
|
leader in Isoform-sleective PI3 kianse inhibitors; demonstrate the clinical benefit of isoform-selective PI3 kinase inhibitors in patients with cancer and inflammatory diseases | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|